REVIEW
|
doi:10.20944/preprints202402.0976.v1
Subject:
Medicine And Pharmacology,
Oncology And Oncogenics
Keywords:
bevacizumab; ovarian cancer; angiogenesis; VEGF
Online: 19 February 2024 (11:19:20 CET)
ARTICLE
|
doi:10.20944/preprints202310.0836.v1
Subject:
Medicine And Pharmacology,
Gastroenterology And Hepatology
Keywords:
hepatocellular carcinoma; unresectable; atezolizumab plus bevacizumab; lenvatinib
Online: 12 October 2023 (15:36:58 CEST)
ARTICLE
|
doi:10.20944/preprints202407.0186.v1
Subject:
Medicine And Pharmacology,
Gastroenterology And Hepatology
Keywords:
atezolizumab; bevacizumab; hepatocellular carcinoma; EGD; varices; GI bleeding
Online: 2 July 2024 (06:01:14 CEST)
ARTICLE
|
doi:10.20944/preprints202405.1426.v1
Subject:
Biology And Life Sciences,
Neuroscience And Neurology
Keywords:
glioblastoma (GBM); recurrent mechanism; bevacizumab (BVZ); E2F family
Online: 22 May 2024 (08:30:26 CEST)
ARTICLE
|
doi:10.20944/preprints202306.1767.v1
Subject:
Medicine And Pharmacology,
Oncology And Oncogenics
Keywords:
hepatocellular carcinoma; tumor marker; atezolizumab plus bevacizumab; prognosis; predictive model
Online: 26 June 2023 (09:42:06 CEST)
CONCEPT PAPER
|
doi:10.20944/preprints201809.0209.v1
Subject:
Medicine And Pharmacology,
Oncology And Oncogenics
Keywords:
ADZT regimen; apremilast; bevacizumab; cAMP; dapsone; glioblastoma; telmisartan; TNF-alpha; zonisamide
Online: 12 September 2018 (03:54:33 CEST)
REVIEW
|
doi:10.20944/preprints202108.0037.v1
Subject:
Medicine And Pharmacology,
Oncology And Oncogenics
Keywords:
ovarian cancer; checkpoint inhibitors; ICIs; immunotherapy; PARP; avelumab; pembrolizumab; nivolumab; bevacizumab; platinum
Online: 2 August 2021 (13:01:35 CEST)
ARTICLE
|
doi:10.20944/preprints202307.1474.v1
Subject:
Medicine And Pharmacology,
Gastroenterology And Hepatology
Keywords:
Hepatocellular carcinoma; Atezolizumab–bevacizumab; Hepatic artery infusion chemotherapy; Overall survival; Progression-free survival
Online: 21 July 2023 (14:00:43 CEST)
ARTICLE
|
doi:10.20944/preprints202310.1682.v1
Subject:
Medicine And Pharmacology,
Gastroenterology And Hepatology
Keywords:
Atezolizumab; bevacizumab; non-alcoholic fatty liver disease; non-alcoholic steato hepatitis; albumin-bilirubin (ALBI) score
Online: 26 October 2023 (09:01:45 CEST)